DOWNLOAD DATA SHEET
Bovimune® Clostri 7 + HS Bacterin-toxoid against clostridial complex and haemophilosis, in injectable suspension. Kind Biological Formulation Injectable Presentations 10 and 50 doses. Registry REG.SAGARPA B-2083-036
  • FORMULA
    Containing toxoids and inactivated whole cultures of Clostridium chauvoei injectable suspension, septicum, sordellii, novyi, haemolyticum perfringens type "C" and "D" and Histophilus somni (Haemophilus somnus) in aluminum hydroxide as adjuvant. The combination of toxoids types C and D also protect against Clostridium perfringens type "B".
  • DESCRIPTION
    INDICATIONS: For use in cattle and healthy sheep as an aid in preventing blackleg caused by Clostridium chauvoei, malignant edema caused by Cl septicum, black disease caused by Cl novyi, gas gangrene caused by Cl sordellii, enterotoxemia... and enteritis caused by Cl. perfringens types B, C and D, and disease caused by H. somni (Haemophilus somnus). Immunity against Cl. Perfringens type B is provided by the beta toxoid Cl. Perfringens Type C and epsilon toxoid Cl. Perfringens type D. DESCRIPTION OF CLOSTRIDIAL DISEASES AND HISTOPHILOSIS: Different species of Clostridia under anaerobic conditions (without oxygen) are able to multiply and produce toxins harmful in some cases lethal to animals. The Clostridia are capable of forming spores and thus live in the environment for long periods of time, including resisting adverse environmental conditions. Depending on the route of entry into the animal, some clostridia can remain opportunistically or latent and multiply if they find favorable conditions, creating a severe infection with the production of toxins that damage the organs or tissues, with potentially fatal if it occurs in large quantities . The route of entry of clostridia may be oral, by pastures, silos or contaminated grains, infecting animals and developing the disease. The use of dirty and contaminated instruments such as needles and syringes and penetrate the subcutaneous tissue of the animal is muscular a usual source of infection. Administration of contaminated medical preparations, traumatic injuries (wounds and lacerations) or derivatives management, as castration, dehorning shoeing and are often risk factors and pathways for the transmission of Clostridia causing injury or death to the animal. Meanwhile, H. somni (Haemophilus somnus) has been identified as a pathogen generator pneumonic infections, thrombotic and I meningo encephalitis reproductive tract. It can be isolated as a single causative agent of pneumonia or in conjunction with Mycoplasma, Pasteurella and Mannheimia haemolytica. It has also been reported as a cause of abortions. Stress conditions favor the development of infection by H. somni (Haemophilus somnus) latent and may contribute to the presentation of septicemic, and pneumonic nervous pictures. Signs of bronchopneumonia in calves and adult cattle by H. somni (Haemophilus somnus) are indistinguishable from moderate or severe pneumonia by Pasteurella multocida pneumonia ydela Mannheimia (Pausterella) haemolytica. Stress conditions favor the development of infection by H. somni (Haemophilus somnus) latent and may contribute to the presentation of septicemic, and pneumonic nervous pictures. Signs of bronchopneumonia in calves and adult cattle by H. somni (Haemophilus somnus) are indistinguishable from moderate or severe pneumonia by Pasteurella multocida pneumonia ydela Mannheimia (Pausterella) haemolytica. Stress conditions favor the development of infection by H. somni (Haemophilus somnus) latent and may contribute to the presentation of septicemic, and pneumonic nervous pictures. Signs of bronchopneumonia in calves and adult cattle by H. somni (Haemophilus somnus) are indistinguishable from moderate or severe pneumonia by Pasteurella multocida pneumonia ydela Mannheimia (Pausterella) haemolytica.
  • DOSE
    Bovines: 5 ml Sheep, Goats: 2.5 mL ROUTE OF ADMINISTRATION: Apply subcutaneously or intramuscularly preferably in Table neck, using aseptic procedures.
  • USE
     VACCINATION PROGRAM: CATTLE: Calves: from the third month of age and a booster 2 to 3 weeks later. Pregnant females: Administer 5 mL subcutaneously and reinforcement 2 to 3 weeks before delivery to confer excellent protection both mother and breeding, the latter through colostrum. Bovines Adults: Administer 5 mL subcutaneously and reinforcement 2 to 3 weeks should ignore or not having previous vaccinations. SHEEP AND GOATS: Hatchlings: a month old and weaning if you have problems enterotoxemias. Pregnant sows: Administer 2.5 ml subcutaneously in the last third of gestation and reinforcement 2 weeks before delivery to give excellent protection to both mother and breeding, the latter through colostrum. Adult animals: Administer 2.5 mL subcutaneously and boosted 2 to 3 weeks later. In all cases depending on the incidence and type of operation revaccinated every 6 or 12 months.
  • WARNINGS
     Shake well before using. Once broached use the contents completely. Keep refrigerated at a temperature between 2 ° and 7 ° C, do not freeze. Any biological can cause anaphylactic reactions. In this case the use of epinephrine followed by appropriate supportive therapy is recommended. This product has proven effective in healthy animals. It can not occur a protective immune response if animals are incubating a stressed infectious disease, immunosuppressed, malnourished, parasitized or due to transport or due to adverse environmental conditions, or whether the vaccine is not administered according to label directions. Do not vaccinate 21 days before slaughter of animals intended for human consumption. Keep out of reach of children. Discard the container safely bury yourself or incinerate. CONSULT YOUR VETERINARIAN.

All rights reserved Lapisa 2018 © | Notice of Privacy